Surgery Partners, Inc. (NASDAQ:SGRY) Given Consensus Recommendation of “Moderate Buy” by Analysts

Shares of Surgery Partners, Inc. (NASDAQ:SGRY) have received an average recommendation of “Moderate Buy” from the ten research firms that are presently covering the stock, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year price target among analysts that have covered the stock in the last year is $36.56.

Several research firms have recently weighed in on SGRY. JPMorgan Chase & Co. dropped their target price on shares of Surgery Partners from $38.00 to $28.00 and set a “neutral” rating for the company in a research report on Tuesday, December 3rd. KeyCorp initiated coverage on shares of Surgery Partners in a research report on Friday, October 11th. They issued a “sector weight” rating for the company. Macquarie reaffirmed an “outperform” rating and issued a $34.00 price target on shares of Surgery Partners in a report on Tuesday, November 19th. Bank of America initiated coverage on shares of Surgery Partners in a report on Monday, December 16th. They issued a “buy” rating and a $30.00 price target for the company. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $43.00 price target on shares of Surgery Partners in a report on Friday, October 4th.

Surgery Partners Stock Performance

Surgery Partners stock opened at $19.85 on Wednesday. Surgery Partners has a 12-month low of $19.50 and a 12-month high of $35.29. The company has a market capitalization of $2.52 billion, a price-to-earnings ratio of -41.35, a price-to-earnings-growth ratio of 17.40 and a beta of 2.58. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66. The firm’s fifty day moving average price is $22.64 and its 200 day moving average price is $27.31.

Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.06). The firm had revenue of $770.40 million for the quarter, compared to analysts’ expectations of $768.99 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The business’s quarterly revenue was up 14.3% on a year-over-year basis. During the same period last year, the firm earned $0.15 EPS. On average, research analysts forecast that Surgery Partners will post 0.71 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of SGRY. Bank of New York Mellon Corp boosted its stake in Surgery Partners by 12.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 347,485 shares of the company’s stock valued at $8,267,000 after purchasing an additional 38,285 shares during the period. Natixis Advisors LLC boosted its holdings in shares of Surgery Partners by 11.0% in the second quarter. Natixis Advisors LLC now owns 12,452 shares of the company’s stock valued at $296,000 after acquiring an additional 1,237 shares in the last quarter. Rhumbline Advisers boosted its holdings in shares of Surgery Partners by 19.6% in the second quarter. Rhumbline Advisers now owns 127,952 shares of the company’s stock valued at $3,044,000 after acquiring an additional 20,963 shares in the last quarter. Arizona State Retirement System boosted its holdings in shares of Surgery Partners by 1.9% in the second quarter. Arizona State Retirement System now owns 19,494 shares of the company’s stock valued at $464,000 after acquiring an additional 359 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its holdings in shares of Surgery Partners by 26.7% in the second quarter. Dimensional Fund Advisors LP now owns 2,801,091 shares of the company’s stock valued at $66,643,000 after acquiring an additional 589,499 shares in the last quarter.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.